HPB Flashcards
Hydatid cyst causative agent
Echinococcus granulosus
Focal modular hyperplasia
Focal nodular hyperplasia is benign
Biopsy is only needed if there is doubt about the diagnosis
Risk of injury to CBD in lap chole
CBD injury with laparoscopic cholecystectomy = 0.3-0.7%
HCC mets
Lungs most comman
Then lymphatic spread
Pancreatic division
In classic pancreatic divisum the Duct of Santorini drains via the minor papilla and the duct of Wirsung drains via the major papilla
Risk factors for pancreatic fistulas
• Pancreatic fistula are the single biggest cause of morbidity following pancreatic resection
• Incidence is approximately 15%, risk lower in distal pancreatectomy
•Clinically significant fistula will have amylase three times the serum amylase level and will give rise to symptoms such as fever and tachycardia
• Risk of fistula is increased if there is a soft pancreas (22%), age over 70 years, long period of jaundice (rather than severity), coronary artery disease and blood loss over 1doomi
How many liver segments need to remain post resection
2 segments on the ipsilateral size correlate approximately to 20-30% of liver volume.
Good outcome when >20% left if underlying problems >40%
Liver regeneration time
4-6months
Main duct IPMN
Lesions which are between 20-30 mm are considered moderate risk and should be further evaluated using US and blood tests for CEA and CA19-9. Percutaneous biopsy is not generally performed.
IPMN histology
Main duct - usually pancreatic-bilary differention
Branching ducts - usually gastric foveolar
Gallbladder polyps
Malignancy more likely in >1cm
Gb cancer
- Represents 2% of all cancers
• Up to 90% cases associated with gallstones
• A polyp - carcinoma sequence does not apply in the gallbladder
• Malignancy is more likely in a gallbladder polyp larger than 1cm diameter
• 60% are located in the fundus
• 6% of patients with porcelain gallbladder will be associated with malignancy
• Treatment of T1 (mucosal disease) is by open cholecystectomy and regional nodal sampling
• T2-T3 disease is managed by formal resection of segments IVb and V
• Overall survival is less than 10% at 5 years.
Hepatic cystadenomas
Up to 10% of cystadenomas are malignant and distinguishing between benign and malignant disease (even on biopsy is difficult). Surgical resection is therefore recommended. Note that in the question, cross sectional imaging has already suggested the diagnosis.
IPMN follow up
Concerning features: enhancing nodule <5mm, elevated ca19.9 increase in growth to >5mm over 2 years
If cystic lesion <1cm thrn CT/MRI every 2 hrs
If >3cm follow up EUS/MRI every 3-6months
IPMN malignancy risk
Main duct - 60-100%
Side duct 25%